Safety and Efficacy of Rivastigmine in Adolescents with Down Syndrome: A Preliminary 20-Week, Open-Label Study

類似資料

• Donepezil for the Treatment of Language Deficits in Adults With Down Syndrome: A Preliminary 24-Week Open Trial
  著者:: Heller, James H., 等
  出版事項: (2003)
• Donepezil Effects on Language in Children With Down Syndrome: Results of the First 22-Week Pilot Clinical Trial
  著者:: Heller, James H., 等
  出版事項: (2004)
• Safety and Efficacy of Rivastigmine in Adolescents with Down Syndrome: Long-Term Follow-Up
  著者:: Heller, James H., 等
  出版事項: (2010)
• Prevalence of Iron Deficiency in Children with Down Syndrome
  著者:: Dixon, Natalia E, 等
  出版事項: (2010)
• Hypothyroidism in Down Syndrome: Screening Guidelines and Testing Methodology
  著者:: Hardy, Olga, 等
  出版事項: (2004)